The biotechnology company posted revenue of $355,000 in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $1.3 ...
News
- Lineage Cell: Q4 Earnings Snapshot
- Ocular Therapeutix: Q4 Earnings Snapshot
The biotechnology company posted revenue of $7.3 million in the period, which also did not meet Street forecasts. Four analysts surveyed by Zacks ...
- Early tracheotomy helps patients avoid ventilator-associated pneumonia, team finds
SAN ANTONIO -- Surgically opening the windpipe, or trachea, within the first ... of Texas Health Science Center at San Antonio (UT Health San Antonio). ... health professions and graduate biomedical sciences have graduated more ...
- Texas Biomed scientists partner with DoD to test SARS-CoV-2 decontamination technologies
SAN ANTONIO (March 11, 2020) - Texas Biomedical Research Institute (Texas Biomed) received two Department of Defense's (DoD) Defense Health ...
- 22nd Century: Q4 Earnings Snapshot
The plant biotechnology company posted revenue of $7.3 million in the period. For the year, the company reported that its loss narrowed to $19.7 ...